استخدام إستخدام الصبغه المناعية (Stathmin 1) كعامل تنبؤي في سرطان الرئه ذو الخلايا غير الصغيره د. نظيمه بهاء حسين , مستشفى الصادق التعليمي- بابل اد . هدبل عبدالاله كربل, كليه طب حمورابي- جامعة بابل اد . علي صالح بيعي , كليه طب حمورابي- جامعة بابل اد . محمد وهيب

Ferlay j, Soerjomataram I,Ervic M,Dikshit R,Eser S,

MathersC et al. Globocan2012v1.0,Cancer Incidence

and Mortality Worldwide:IARC CancerBase No.11.

Yoshizawa A, Motoi N, Riely GJ, et al. Impact of

proposed IASLC/ATS/ERS classification of lung

adenocarcinoma: prognostic subgroups and

implications for further revision of staging based on

analysis of 514 stage I cases. Mod Pathol.

;24(5):653-664.

Iancu-Rubin C, Nasrallah CA, Atweh GF. Stathmin

prevents the transition from a normal to an endomitotic

cell cycle during megakaryocytic differentiation. Cell

Cycle (Georgetown, Tex) 2005;4(12):1774-82.

Alli E, Yang JM, Hait WN. Silencing of stathmin

induces tumor-suppressor function in breast cancer cell

lines harboring mutant p53. Oncogene

;26(7):1003-12 17.

Mistry SJ, Benham CJ, Atweh GF. Development of

ribozymes that target stathmin, a major regulator of the

mitotic spindle. Antisense Nucleic Acid Drug Dev

;11(1):41-9 .

Yuan RH, Jeng YM, Chen HL, et al. Stathmin

overexpression cooperates with p53 mutation and

osteopontin overexpression, and is associated with

tumour progression, early recurrence, and poor

prognosis in hepatocellular carcinoma. J Pathol 2006;

:549–558.

Biaoxue R, Liu Hua, Fu Tian, Gao Wenlong,

Increased stathmin in serum as a potential tumor

marker for lung adenocarcinoma. Japanese Journal of

Clinical Oncology, Volume 47, Issue 4, April 2017,

–349.

Immunohistochemical Study of Stathmin-1 as A Prognostic factor In Nadhema B. Hussein

Non-small cell lung carcinoma.

J Fac Med Baghdad 202 Vol.64 No. 4, 2022

Kouzu Y, Uzawa K, Koike H, Saito K, Nakashima D,

Higo M, et al. Overexpression of stathmin in oral

squamous-cell carcinoma: correlation with tumour

progression and poor prognosis. Br J Cancer. 2006;94:

-23.

Belletti B, Baldassarre G. Stathmin: a protein with

many tasks. New biomarker and potential target in

cancer. Expert Opin Ther Targets. 2011; 15:1249-66.

Yurong L, Rong Biaoxue, Li Wei et al. Stathmin

overexpression is associated with growth, invasion and

metastasis of lung adenocarcinoma: Oncotarget. 2017;

:16 ,26000-26012.

Biaoxue R, Increased stathmin in serum as a

potential tumor marker for lung adenocarcinoma.

Japanese Journal of Clinical Oncology. 2017; 7: 47

-668.

Shimizu K. Prognostic impact of stathmin 1

expression in patients with lung adenocarcinoma. The

Journal of Thoracic and Cardiovascular Surgery.

:4,154, 1406-1417.